As of 30 Sep 2025, 7 institutional investors reported holding $4,500,000 in principal (par value) of EVOLENT HEALTH INC - NOTE 1.500%10/1.
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | $4,500,000 | $4,463,668 | -$167,578,453 | 99.31% | 7 |
| 2025 Q2 | $173,633,000 | $171,973,796 | +$113,208 | 98.52% | 10 |
| 2025 Q1 | $173,682,000 | $170,808,890 | +$1,915,041 | 97.73% | 9 |
| 2024 Q4 | $171,719,000 | $167,318,058 | -$12,154,486 | 96.88% | 9 |
| 2024 Q3 | $182,962,000 | $193,561,523 | -$526,399 | 105.04% | 14 |
| 2024 Q2 | $181,685,500 | $181,195,280 | +$981,942 | 96.88% | 14 |
| 2024 Q1 | $180,676,500 | $209,850,274 | +$13,173,199 | 114.29% | 10 |
| 2023 Q4 | $169,263,851 | $196,559,962 | +$5,230,022 | 114.3% | 12 |
| 2023 Q3 | $166,587,063 | $179,342,224 | +$3,299,805 | 106.81% | 14 |
| 2023 Q2 | $162,822,732 | $187,025,288 | -$7,530,934 | 114.14% | 18 |
| 2023 Q1 | $167,398,674 | $200,614,787 | -$6,527,176 | 119.14% | 16 |
| 2022 Q4 | $177,270,000 | $192,085,833 | -$6,295,655 | 107.99% | 23 |
| 2022 Q3 | $161,533,061 | $203,978,640 | -$1,825,000 | 125.78% | 23 |
| 2022 Q2 | $164,442,261 | $186,382,974 | -$7,254,023 | 113.34% | 22 |
| 2022 Q1 | $169,093,061 | $208,322,169 | +$6,285,511 | 118.32% | 23 |
| 2021 Q4 | $158,664,761 | $173,507,093 | -$4,442,236 | 109.48% | 21 |
| 2021 Q3 | $162,114,761 | $185,920,476 | +$11,459,344 | 114.65% | 23 |
| 2021 Q2 | $155,842,126 | $150,049,654 | -$8,438,383 | 96.52% | 21 |
| 2021 Q1 | $164,752,126 | $154,692,331 | -$3,977,127 | 94.06% | 23 |
| 2020 Q4 | $172,112,000 | $147,174,089 | +$11,566,638 | 85.87% | 21 |
| 2020 Q3 | $160,440,000 | $125,624,189 | +$64,763 | 78.52% | 17 |
| 2020 Q2 | $154,989,000 | $102,819,113 | -$5,801,384 | 63.36% | 19 |
| 2020 Q1 | $164,203,000 | $107,710,360 | +$5,522,069 | 63.16% | 20 |
| 2019 Q4 | $163,038,000 | $117,284,007 | +$117,284,007 | 69.75% | 20 |